GAITHERSBURG, Md.--(BUSINESS WIRE)--Bridge Laboratories announced today that it has reached an agreement to build its second preclinical facility in China. This purpose built, 150,000 square foot facility will be adjacent to Bridge’s existing laboratory in the Zhongguancun Life Science Park located in Beijing, China.
